Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001437749-20-011845
Filing Date
2020-05-27
Accepted
2020-05-27 16:57:43
Documents
1
Effectiveness Date
2020-05-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12474
  Complete submission text file 0001437749-20-011845.txt   13914
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-367789 | Film No.: 20916006
SIC: 2834 Pharmaceutical Preparations